Clearside Biomedical, Inc.
CLSDQ
$0.95
$0.1215.14%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -71.17% | -68.07% | -61.45% | -30.77% | -18.09% |
| Total Receivables | -66.24% | -- | -- | 8.57% | -10.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 64.63% | 334.07% | 27.16% | 1.66% | -35.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -70.45% | -60.10% | -7.14% | -7.14% |
| Total Current Assets | -67.13% | -60.41% | -55.80% | -29.38% | -18.50% |
|
|
|||||
| Total Current Assets | -67.13% | -60.41% | -55.80% | -29.38% | -18.50% |
| Net Property, Plant & Equipment | -16.45% | -14.97% | -8.08% | -1.11% | 12.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -60.08% | -54.82% | -51.00% | -26.14% | -15.28% |
|
|
|||||
| Total Accounts Payable | -66.29% | -28.36% | 40.43% | -34.15% | 26.46% |
| Total Accrued Expenses | -44.39% | -58.49% | -33.17% | -28.83% | -20.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.95% | 2.97% | 3.00% | 3.02% | 3.04% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -50.47% | -48.13% | -15.76% | -29.63% | -4.15% |
|
|
|||||
| Total Current Liabilities | -50.47% | -48.13% | -15.76% | -29.63% | -4.15% |
| Long-Term Debt | 24.35% | 19.20% | 20.38% | 23.29% | 20.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -84.95% | -69.17% | -57.87% | -49.46% | -43.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -81.82% | -43.37% | -37.63% | 1,377.50% | -- |
| Total Liabilities | 2.57% | 2.97% | 5.85% | 28.14% | 35.29% |
|
|
|||||
| Common Stock & APIC | 2.18% | 2.33% | 2.16% | 3.74% | 3.28% |
| Retained Earnings | -7.47% | -8.14% | -9.26% | -10.70% | -10.09% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -55.08% | -72.30% | -110.50% | -144.19% | -170.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -55.08% | -72.30% | -110.50% | -144.19% | -170.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -55.08% | -72.30% | -110.50% | -144.19% | -170.75% |
|
|
|||||